Gene112
ADCY6: adenylate cyclase 6
Cite this record
ConductScience Library. ADCY6: adenylate cyclase 6. Genes, record 112. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/112
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O43306 | Adenylate cyclase type 6 | 1,168 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents85
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 4323 | O43306 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 291 | O43306 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36698 | O43306 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4755 | O43306 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4323 | O43306 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 4755 | O43306 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 291 | O43306 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 291 | O43306 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 291 | O43306 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4323 | O43306 | Espacenet |
NIH grants689
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ADCY6 papers | Newest fiscal year |
|---|---|---|---|
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 4 | 2025 |
| I01BX003774 | Urocortin 2 Gene Transfer for Heart Failure with Preserved Ejection Fraction | 3 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| IK6BX004475 | BLRD Research Career Scientist Award Application | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 2 | 2025 |
| P30DK034989 | Yale Liver Center | 2 | 2025 |
| P30EY014801 | Miami Center for Vision Research | 2 | 2025 |
| R01DK058816 | ADPKD: Disease Spectrum & Genotype-Phenotype Correlations | 2 | 2025 |
Source NIH's project files
Papers816
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opposing Ageing-Related Transcriptomic Profiles Distinguish Opioid Exposure Liability From Dependence Liability. | Cureus | 2026 | 42339106 | PubTator, text mining | PubMed |
| CPSF2-mediated 3' UTR truncation of MTERF3 drives mitochondrial dysfunction and osteosarcoma progression. | Oncogene | 2026 | 42286305 | PubTator, text mining | PubMed |
| miR-152-3p inhibits triple-negative breast cancer cell progression by targeting signal transducer and activator of transcription 3, nuclear factor kappa B subunit p65 and adenylate cyclase 6. | Pak J Pharm Sci | 2026 | 42170979 | PubTator, text mining | PubMed |
| Severe Hypoxia Reduces Adenylyl Cyclase 6 Expression and Function in Bronchial Epithelial Cells. | FASEB Bioadv | 2026 | 42004995 | PubTator, text mining | PubMed |
| The Role of A-Kinase Anchoring Proteins for Inhibitory cAMP Signalling in Platelets. | Cells | 2026 | 41892342 | PubTator, text mining | PubMed |
The antinuclear antibody HEp-2 indirect immunofluorescence harmonization and competency assessment program of the Society for Clinical Microbiologists of Türkiye: analysis of 7-year assessment results. | Lab Med | 2026 | 41832787 | PubTator, text mining | PubMed |
| Development and psychometric validation of caring leadership scale in nursing. | PLoS One | 2026 | 41770765 | PubTator, text mining | PubMed |
| Chromosome 3p Deletion Leads to Extensive Genomic Alterations in Diverse Cancers and Confers Synthetic Lethality in Uveal Melanoma. | Cancers (Basel) | 2026 | 41749941 | PubTator, text mining | PubMed |
| Gene Therapy for Heart Failure. | J Cardiovasc Transl Res | 2026 | 41642391 | PubTator, text mining | PubMed |
| Evaluation of acridine derivatives as acetylcholinesterase inhibitors: Cytotoxicity, molecular interactions, and neuroprotective potential in AD. | Behav Brain Res | 2026 | 40998260 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/112
GET https://conductscience.org/api/genes/v1/112/patents?page=2